Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry presenters will focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development

SAN CARLOS, CA, January 30, 2012 /24-7PressRelease/ -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that Mike Reed, PhD, Vice President of Client Services, will participate in a roundtable panel to discuss " The Use of Physiological, Mechanistic Models in Drug Development and Therapy: Introduction, Case Studies, Impact, and Ideas for Applications". This is a local event sponsored by the American Society of Pharmacometrics (ASoP), to be held on Thursday, February 2, 2012, in Bridgewater, New Jersey. At this roundtable, industry experts will summarize the benefits and challenges in using physiological models for drug development, describe the modeling approaches used, report on program outcomes, and share ideas for the future of modeling. Registration for the event can be found at http://www.go-asop.org/physiological-models-NJ.

Press Release Contact Information:

Rebecca Baillie
Rosa & Co
Chief Scientist
751 Laurel St., Ste. 127
San Carlos, CA
USA 94070
Voice: 530-661-7476
Website: Visit Our Website